We’re improving your experience!

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03437200
Title Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer (CRUCIAL)
Acronym CRUCIAL
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | ESP

Facility Status City State Zip Country Details
Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere Paris 75651 France Details
Institut Gustave Roussy Villejuif 94805 France Details
Hospital Del Mar Barcelona 08003 Spain Details
Institut Catala d'Oncologia - ICO Badalona - Hospital De Mataro Barcelona 08304 Spain Details
Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) Barcelona 08908 Spain Details
Hospital Universitario de Gran Canaria Doctor Negrin Las Palmas De Gran Canaria 35019 Spain Details
Hospital Universitario 12 De Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field